Literature DB >> 7475591

Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver.

M R Teli1, C P Day, A D Burt, M K Bennett, O F James.   

Abstract

"Pure" alcoholic fatty liver has been widely assumed to be "benign" with very low risk of progression to cirrhosis. Studies thus far have included either patients with coexisting recognised precursor lesions of cirrhosis or have been restricted to short-term histological follow-up. We have followed 88 patients, first seen between 1978 and 1985, with a histological diagnosis of pure alcoholic fatty liver and no evidence of fibrosis or alcoholic hepatitis, for a median of 10.5 years, to determine any factors predictive of disease progression. Of the 88, at follow-up nine had developed cirrhosis and a further seven fibrosis. Eight of nine patients with cirrhosis had continuing alcohol consumption of more than 40 units per week at follow-up; in the other patients, consumption was unknown. Independent histological predictors of progression on index biopsy were: presence of mixed macro/microvesicular fat, and presence of giant mitochondria. We can no longer regard alcoholic fatty liver as benign. In the presence of continuing high alcohol consumption the above histological features identified those at high risk (47-61%) of disease progression. Therefore, patients with these features should be counselled intensively regarding their alcohol consumption.

Entities:  

Mesh:

Year:  1995        PMID: 7475591     DOI: 10.1016/s0140-6736(95)91685-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  126 in total

Review 1.  Mechanisms and cell signaling in alcoholic liver disease.

Authors:  Juliane I Beier; Craig J McClain
Journal:  Biol Chem       Date:  2010-11       Impact factor: 3.915

Review 2.  The Hepatic Lipidome: A Gateway to Understanding the Pathogenes is of Alcohol-Induced Fatty Liver.

Authors:  Robin D Clugston; Madeleine A Gao; William S Blaner
Journal:  Curr Mol Pharmacol       Date:  2017       Impact factor: 3.339

3.  Portal lymphadenopathy predicts non-alcoholic steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease.

Authors:  Saleh Daher; Namma Lev Cohen; Muhammad Massarwa; Mahmud Mahamid; Mira Nasser; Wadi Hazou; Rani Oren; Rifaat Safadi; Tawfik Khoury
Journal:  PLoS One       Date:  2018-11-30       Impact factor: 3.240

Review 4.  Best practice in primary care pathology: review 5.

Authors:  W S A Smellie; J Forth; S Ryder; M J Galloway; A C Wood; I D Watson
Journal:  J Clin Pathol       Date:  2006-04-27       Impact factor: 3.411

5.  Intestinal Fungal Dysbiosis and Systemic Immune Response to Fungi in Patients With Alcoholic Hepatitis.

Authors:  Sonja Lang; Yi Duan; Jinyuan Liu; Manolito G Torralba; Claire Kuelbs; Meritxell Ventura-Cots; Juan G Abraldes; Francisco Bosques-Padilla; Elizabeth C Verna; Robert S Brown; Victor Vargas; Jose Altamirano; Juan Caballería; Debbie Shawcross; Michael R Lucey; Alexandre Louvet; Philippe Mathurin; Guadalupe Garcia-Tsao; Samuel B Ho; Xin M Tu; Ramon Bataller; Peter Stärkel; Derrick E Fouts; Bernd Schnabl
Journal:  Hepatology       Date:  2019-08-20       Impact factor: 17.425

6.  Targeting the gut barrier for the treatment of alcoholic liver disease.

Authors:  Zhanxiang Zhou; Wei Zhong
Journal:  Liver Res       Date:  2017-12

7.  Long term prognosis of fatty liver: risk of chronic liver disease and death.

Authors:  S Dam-Larsen; M Franzmann; I B Andersen; P Christoffersen; L B Jensen; T I A Sørensen; U Becker; F Bendtsen
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

8.  Ethanol exposure depletes hepatic pigment epithelium-derived factor, a novel lipid regulator.

Authors:  Chuhan Chung; Christine Shugrue; Anil Nagar; Jennifer A Doll; Mona Cornwell; Arijeet Gattu; Tom Kolodecik; Stephen J Pandol; Fred Gorelick
Journal:  Gastroenterology       Date:  2008-10-07       Impact factor: 22.682

9.  Night workers with circadian misalignment are susceptible to alcohol-induced intestinal hyperpermeability with social drinking.

Authors:  Garth R Swanson; Annika Gorenz; Maliha Shaikh; Vishal Desai; Thomas Kaminsky; Jolice Van Den Berg; Terrence Murphy; Shohreh Raeisi; Louis Fogg; Martha Hotz Vitaterna; Christopher Forsyth; Fred Turek; Helen J Burgess; Ali Keshavarzian
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-05-19       Impact factor: 4.052

Review 10.  Management of alcohol misuse in patients with liver diseases.

Authors:  Jennifer L Peng; Milan Prakash Patel; Breann McGee; Tiebing Liang; Kristina Chandler; Sucharat Tayarachakul; Sean O'Connor; Suthat Liangpunsakul
Journal:  J Investig Med       Date:  2016-12-09       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.